May 3 |
Strong week for Enanta Pharmaceuticals (NASDAQ:ENTA) shareholders doesn't alleviate pain of five-year loss
|
Apr 30 |
Enanta Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Apr 30 |
Enanta Pharmaceuticals Announces the Appointment of Matthew P. Kowalsky as Chief Legal Officer
|
Apr 29 |
Enanta Pharmaceuticals to Host Conference Call on May 6 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2024
|
Apr 17 |
Enanta Pharmaceuticals Announces Data Presentation at ESCMID Global 2024
|
Mar 6 |
Enanta Pharmaceuticals to Participate at Leerink Partners Global Biopharma Conference
|
Feb 12 |
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Consensus Forecasts Have Become A Little Darker Since Its Latest Report
|
Feb 8 |
Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Q1 2024 Earnings Call Transcript
|
Feb 8 |
Q1 2024 Enanta Pharmaceuticals Inc Earnings Call
|
Feb 8 |
Enanta Pharmaceuticals, Inc. (ENTA) Q1 2024 Earnings Call Transcript
|